Influence of immunotherapy with pegylated interferon-alpha on platelet monoamine oxidase activity in high-risk melanoma patients

被引：0
|
作者：
Fekkes, D [1 ]
van Gool, AR [1 ]
van Ojik, HH [1 ]
Bannink, M [1 ]
Mulder, PGH [1 ]
Kruit, WHJ [1 ]
Eggermont, AMM [1 ]
Stoter, G [1 ]
机构：
[1] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2004年 / 14卷
关键词：
D O I：
10.1016/S0924-977X(04)80165-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S206 / S207
页数：2
相关论文
共 50 条
  • [41] Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trialaEuro
    Eigentler, T. K.
    Gutzmer, R.
    Hauschild, A.
    Heinzerling, L.
    Schadendorf, D.
    Nashan, D.
    Hoelzle, E.
    Kiecker, F.
    Becker, J.
    Sunderkoeter, C.
    Moll, I.
    Richtig, E.
    Poenitzsch, I.
    Pehamberger, H.
    Kaufmann, R.
    Pfoehler, C.
    Vogt, T.
    Berking, C.
    Praxmarer, M.
    Garbe, C.
    ANNALS OF ONCOLOGY, 2016, 27 (08) : 1625 - 1632
  • [42] Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma
    Jonasch, E
    Kumar, UN
    Linette, GP
    Hodi, FS
    Soiffer, RJ
    Ryan, BF
    Sober, AJ
    Mihm, MC
    Tsao, H
    Langley, RG
    Cosimi, BA
    Gadd, MA
    Tanabe, KK
    Souba, W
    Haynes, HA
    Barnhill, R
    Osteen, R
    Haluska, FG
    CANCER JOURNAL, 2000, 6 (03): : 139 - 145
  • [43] Long-term survival in a case of high-risk type IgD myeloma; a possibility of effectiveness of interferon-alpha and erythropoietin
    Hiyoshi, M
    Hashimoto, S
    Ota, T
    Nakao, T
    Takubo, T
    Tagawa, S
    Tatsumi, N
    HAEMATOLOGIA, 1997, 28 (03) : 177 - 180
  • [44] Association of HLA polymorphism and outcome in high-risk Greek melanoma patients receiving adjuvant interferon
    Spyropoulou-Vachou, Maria
    Gogas, Helen
    Dafni, Urania
    Tsoutsos, Dimosthenis
    Vrani, Vasiliki
    Dinou, Melina
    Stavropoulos-Giokas, Catherine
    TISSUE ANTIGENS, 2009, 73 (05): : 519 - 519
  • [45] Evaluation of CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon
    Gogas, H.
    Metaxas, Y.
    Dafni, U.
    Polyzos, A.
    Fountzilas, G.
    Pectasides, E.
    Skarlos, D.
    Tsoutsos, D.
    Panagiotou, P.
    Spyropoulou-Vlachou, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] Cost-effectiveness analysis of interferon as adjuvant therapy in high-risk melanoma patients in Spain
    González-Larriba, JL
    Serrano, S
    Alvarez-Mon, M
    Camacho, F
    Casado, MA
    Díaz-Pérez, JL
    Díaz-Rubio, E
    Fosbrook, L
    Guillem, V
    López-López, JJ
    Moreno-Nogueira, JA
    Toribio, J
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (18) : 2344 - 2352
  • [47] Evaluation of IL-10 polymorphisms in high-risk melanoma patients receiving adjuvant interferon
    Gogas, H.
    Metaxas, Y.
    Polyzos, A.
    Mantzourani, M.
    Antoniadis, A.
    Floudas, C.
    Fountzilas, G.
    Pectasides, D.
    Tsoutsos, D.
    Spyropoulou-Vlachou, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma
    Suarez-Kelly, Lorena P.
    Levine, Kala M.
    Olencki, Thomas E.
    del Campo, Sara E. Martin
    Streacker, Elizabeth A.
    Brooks, Taylor R.
    Karpa, Volodymyr I.
    Markowitz, Joseph
    Bingman, Anissa K.
    Geyer, Susan M.
    Kendra, Kari L.
    Carson, William E.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (04) : 619 - 629
  • [49] A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma
    Lorena P. Suarez-Kelly
    Kala M. Levine
    Thomas E. Olencki
    Sara E. Martin del Campo
    Elizabeth A. Streacker
    Taylor R. Brooks
    Volodymyr I. Karpa
    Joseph Markowitz
    Anissa K. Bingman
    Susan M. Geyer
    Kari L. Kendra
    William E. Carson
    Cancer Immunology, Immunotherapy, 2019, 68 : 619 - 629
  • [50] Activation of platelet-activating factor (PAF) in high-risk melanoma patients with nodal metastasis
    McMasters, Austin
    Chariker, Julia
    Hwang, Jae Yeon
    Yin, Xinmin
    Ma, Xipeng
    Xu, Raobo
    Zhang, Xiang
    Park, Juw Won
    McMasters, Kelly M.
    Hao, Hongying
    CANCER RESEARCH, 2024, 84 (06)
12345